Imexpharm Corp (IMP) — Defensive Interval Ratio

Latest as of June 2026: 584 days

Imexpharm Corp (IMP) has a Defensive Interval Ratio of 584 days as of June 2026. Defensive assets of ₫802.41 Billion (cash ₫-, short-term investments ₫346.67 Billion, receivables ₫455.73 Billion) cover 584 days of daily cash needs of ₫1.38 Billion/day.

Defensive Interval Ratio

584 days
Days of operational coverage

Defensive Assets

₫802.41 Billion
Cash + ST Investments + Receivables

Daily Cash Need

₫1.38 Billion
Current Liabilities ÷ 365

Current Liabilities

₫501.92 Billion
VND

Imexpharm Corp Defensive Interval Ratio (2019–2025)

This chart shows how Imexpharm Corp's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 584 days, meaning defensive assets of ₫802.41 Billion can fund 584 days of operations without new revenue. For the complete balance sheet picture, see Imexpharm Corp assets under control.

Annual Defensive Interval Ratio for Imexpharm Corp (2019–2025)

The table below presents the year-by-year Defensive Interval Ratio for Imexpharm Corp from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See how liquid is Imexpharm Corp's working capital to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (VND) Daily Cash Need Cash ST Investments Change (days)
2025 529 days ₫539.85 Billion ₫1.02 Billion/day ₫- ₫212.10 Billion ▼ -16 days
2024 545 days ₫480.51 Billion ₫881.25 Million/day ₫- ₫142.00 Billion ▲ +131 days
2023 415 days ₫349.81 Billion ₫843.93 Million/day ₫- ₫93.00 Billion ▼ -8 days
2022 422 days ₫442.48 Billion ₫1.05 Billion/day ₫- ₫211.30 Billion ▲ +101 days
2021 321 days ₫359.47 Billion ₫1.12 Billion/day ₫- ₫112.45 Billion ▼ -98 days
2020 419 days ₫398.24 Billion ₫950.50 Million/day ₫- ₫63.61 Billion ▲ +53 days
2019 366 days ₫263.02 Billion ₫719.05 Million/day ₫- ₫5.19 Billion
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)